E-DRUG: New Book: Pharmaceutical Prices in the 21st Century
----------------------------------------------------------------------------------------------------
Babar, Zaheer-Ud-Din (Ed.)
2015, X, 411 p. 37 illus., 34 illus. in color.
ISBN 978-3-319-12168-0
http://www.springer.com/adis/book/978-3-319-12168-0
Description:
The book is an essential, comprehensive text on global drug pricing and covers a range of pharmaceutical pricing issues. It has twenty-two chapters in total; nineteen country case studies while three are special chapters.
Contents
1. Pharmaceutical Pricing Policies in Australia . Agnes Isabelle Vitry, Loc Thai, and Elizabeth E. Roughead
2. Drug Pricing in Canada........................... Joel Lexchin
3. Pharmaceutical Pricing Policies in China.............. Yu Fang
4. Pharmaceutical Pricing in Egypt.................... Heba Wanis
5. Pharmaceutical Pricing in Ethiopia.................. Eskinder Eshetu Ali, Anwarul-Hassan Gilani, and Teferi Gedif
6. Drug Prices in Finland............................ Katja M. Hakkarainen, Akseli Kivioja, and Leena K. Saastamoinen
7. Pharmaceutical Prices in India............................ Sudip Chaudhuri
8. Pharmaceutical Pricing Policies in Italy..................... Claudio Jommi and Paola Minghetti
9. Pharmaceutical Pricing Policies in South Korea............... Iyn-Hyang Lee and Karen Bloor
10. Pharmaceutical Pricing in Malaysia..........Mohamed Azmi Hassali, Ching Siang Tan, Zhi Yen Wong, Fahad Saleem, and Alian A. Alrasheedy
11. Pharmaceutical Pricing in New Zealand..................... Rajan Ragupathy, Kate Kilpatrick, and Zaheer-Ud-Din Babar
12. Pharmaceutical Pricing Policies in Norway and Sweden . . . . . . . . . Helle Ha ĚŠkonsen and Karolina Andersson Sundell
13. Pharmaceutical Pricing Policies in Qatar.................... Mohamed Izham Mohamed Ibrahim
14. Pharmaceutical Pricing in South Africa..................... Andy Gray and Fatima Suleman
15. Politics, Reforms, and Regulation of Pharma Prices and Expendituresin Turkey over the 2000s...................... Ipek Eren Vural
16. Pharmaceutical Pricing Policies in the Gulf Countries' Council (GCC) and the United Arab Emirates (UAE). . . . . . . . . . . . . . . . . Ranya Shaban Ibrahim Hasan and Charon Lessing
17. The Healthcare System and Pharmaceutical Prices in UnitedStates................. Albert I. Wertheimer and Ming-Yi Huang
18. Pharmaceutical Pricing Policies inVietnam.................. Tuan Anh Nguyen and Elizabeth E. Roughead
19. Pharmaceutical Pricing in Europe......................... Sabine Vogler and Jaana E. Martikainen
20. UK Health Technology Assessment and Value Based Pricing . . . . Emma E. Morrison and David J. Webb
21. Drug Prices and Incentives to Innovation by the Pharmaceutical Industry................Rosella Levaggi and Paolo Pertile
22. The Pharmaceutical Policy Environment and Pharmaceutical Pricing Policies.......................... Christine Y. Lu
Kind Regards
Zaheer
Zaheer-Ud-Din Babar, PhD
Head of Pharmacy Practice
School of Pharmacy
Faculty of Medical and Health Sciences
University of Auckland, Private Mail Bag 92019, Auckland
New Zealand
Zaheer-Ud-Din Babar <z.babar@auckland.ac.nz>